Nuclear imaging equipment uses radioactive substances or tracers for the purpose of imaging. These images aid physicians and clinicians in detection and diagnosis of the illness. The development of advanced imaging equipment for fulfillment of the increasing requirement for enhanced diagnostics is leading to development in this market. These technologically advanced equipment have surpassed the conventional systems due to better precision and accuracy of images. Increasing incidence of chronic diseases such as cardiac disorders, cancer, and neurological disorders, technological advancements, and growing awareness about the early diagnosis have fueled the growth of the medical imaging systems market. In addition, increasing aging population, growing demand for imaging system procedures, and growing expenditure on healthcare would further fuel the market growth. However, expensive imaging systems coupled with unfavorable government initiatives have hindered the growth of the market in developing regions. Nuclear imaging is used in hospitals and medicines to provide a physician with apparatus for making an accurate diagnosis. This helps in deduction of treatment recommendations and to possibility of repeating of errors. Simplification of image evaluation process will help in successful identification of health issues. The advancement of nuclear imaging technology will also be beneficial for up gradation of precision and standardization in imaging techniques for clinical trials.
Increasing government initiatives for the use of modern technologies in healthcare and expansion of infrastructure is expected to drive this market. The introduction of many new manufacturers in this region will increasing the market size for nuclear imaging equipment. This market is presently consolidated and there are few manufacturers who own maximum share of the market.
Nuclear imaging equipment is used in oncology, cardiology, neurology and others. The oncology applications segment is expected to account for the largest share of the global market. The increasing occurrence of tumors is driving the use of this imaging technique and is projected to register the highest growth rate in the forecast period. The growing occurrence and incidence of cancer across the globe and increasing initiatives by public and private organizations to curb the same in driving the demand for this market. The expansion of advanced systems and radiotracers for oncology are the factors liable for the high growth rate of this segment.
On the basis of end user, the nuclear imaging equipment market is segmented into imaging centers, hospitals, academic, research organization and other end users. The other uses of nuclear imaging are found in pharmaceutical, biotechnology companies and contract research organization (CRO). The rising healthcare expenditure across the globe in driving the demand in hospital segment and is forecasted to hold the largest share during the forecast period of 2016-2024. This segment will also grow at the highest CAGR during the forecast period.
This rise in demand can be accredited to features such as the necessity to improve the effectiveness of diagnostic imaging processes and rising number of these procedures undertaken in hospitals. Also, hospitals are expected to provide the most advanced technology and quality of life care possible. This factor will increase the adoption of advanced nuclear imaging systems in the centers.
By region the market has been segmented into: North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. This market is expected to witness the highest growth in the Asia-Pacific region. Increasing occurrence of various life threatening diseases like cancer, tumors etc. in this region is expected to drive the market for this region.
The major manufacturers of nuclear imaging equipment in global market are Digirad Corporation, SurgicEye GmbH, Siemens Healthineers, GE Healthcare, Philips Healthcare, Toshiba Medical Systems Corporation, Neusoft Medical Systems Co. Ltd., Mediso Medical Imaging Systems Ltd., CMR Naviscan Corporation and DDD Diagnostics amongst others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.